WEST LAFAYETTE, Ind., May 25, 2023 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that Robert Leasure Jr., President and…Read More
Related Posts
Life Science Microscope Market Size is Projected to Reach USD 2800 Million by 2030 Growing…
NEW YORK, United States, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled "Life Science Microscopes Market By Product Type (Optical Microscopes, Electron…
Armis Biopharma Announces Receipt of a 203 Million Contract with the Defense Threat Reduction Agency…
FORT COLLINS, Colo., Oct. 4, 2023 /PRNewswire/ -- Armis Biopharma, Inc. announced today that the company received a $20.3 million contract from the Defense Threat Reduction Agency (DTRA) to develop…
Cambrex Opens New Stability Storage Facility in Belgium
EAST RUTHERFORD, N.J., April 4, 2023 /CNW/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug…
